Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr;38(4):e5819.
doi: 10.1002/bmc.5819. Epub 2023 Dec 26.

Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantification of the acetyl-coenzyme A competitive p300/CBP catalytic inhibitor A-485 in biological samples

Reinhard Oertel  1 , Nikolai Jaschke  2 , Annemarie Lippert  1 , Bertold Renner  1
Affiliations

Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantification of the acetyl-coenzyme A competitive p300/CBP catalytic inhibitor A-485 in biological samples

Reinhard Oertel et al. Biomed Chromatogr. 2024 Apr.

Abstract

The small molecule A-485 competitively inhibits the histone acetyltransferase domain of CBP (cyclic-adenosine monophosphate response element-binding protein)/p300. Apart from its antineoplastic activity, researchers are exploring its potential benefits in treating osteoporosis and its impact on energy metabolism. However, so far, only limited pharmacokinetic data are available, and the crucial determination of A-485 concentration in various biological materials with small sample volumes remains unpublished. A rapid and sensitive LC-tandem mass spectrometry method has been developed and validated to quantify A-485 in mouse serum and tissue. In this method, serum samples underwent precipitation with acetonitrile, while cell lysates were appropriately diluted. The determination of A-485 utilized a reversed-phase column with a mobile phase gradient, and detection was carried out in multiple reaction monitoring mode. The lower standard sample, with a concentration of 7.8 ng/mL, served as the lower limit of quantification, while the upper standard was established at 1000 ng/mL. A-485 concentrations were assessed in both serum samples and the lysate of all examined tissues, revealing swift metabolic clearance. The analytical method outlined here is deemed appropriate for subsequent studies. The ability to measure the active ingredient in various compartments facilitates the determination of accurate pharmacokinetic parameters. In the event of human use of A-485, the analysis method can be seamlessly transferred to human samples.

Keywords: A-485; LC-MS/MS; protein precipitation; serum and tissue samples.

PubMed Disclaimer

References

REFERENCES

    1. Ji, C., Xu, W., Ding, H., Chen, Z., Shi, C., Han, J., Yu, L., Qiao, N., Zhang, Y., Cao, X., Zhou, X., Cheng, H., Feng, H., Luo, C., Li, Z., Zhou, B., Ye, Z., & Zhao, Y. (2022). The p300 inhibitor A-485 exerts antitumor activity in growth hormone pituitary adenoma. The Journal of Clinical Endocrinology and Metabolism, 107(6), e2291-e2300. https://doi.org/10.1210/clinem/dgac128
    1. Jia, L., Tomaszewski, J. E., Hanrahan, C., Coward, L., Noker, P., Gorman, G., Nikonenko, B., & Protopopova, M. (2005). Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug. British Journal of Pharmacology, 144(1), 80-87. https://doi.org/10.1038/sj.bjp.0705984
    1. Lasko, L. M., Jakob, C. G., Edalji, R. P., Qiu, W., Montgomery, D., Digiammarino, E. L., Hansen, T. M., Risi, R. M., Frey, R., Manaves, V., Shaw, B., Algire, M., Hessler, P., Lam, L. T., Uziel, T., Faivre, E., Ferguson, D., Buchanan, F. G., Martin, R. L., … Bromberg, K. D. (2017). Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours. Nature, 550(7674), 128-132. https://doi.org/10.1038/nature24028
    1. Peng, J., Li, J., Huang, J., Xu, P., Huang, H., Liu, Y., Yu, L., Yang, Y., Zhou, B., Jiang, H., Chen, K., Dang, Y., Zhang, Y., Luo, C., & Li, G. (2019). p300/CBP inhibitor A-485 alleviates acute liver injury by regulating macrophage activation and polarization. Theranostics, 9(26), 8344-8361. https://doi.org/10.7150/thno.30707
    1. Wu, Y. S., Khanna, R., Schmith, V., Lun, Y., Shen, J. S., Garcia, A., Dungan, L., Perry, A., Martin, L., Tsai, P. C., Hamler, R., das, A. M., Schiffmann, R., & Johnson, F. K. (2021). Migalastat tissue distribution: Extrapolation from mice to humans using pharmacokinetic modeling and comparison with agalsidase beta tissue distribution in mice. Clinical Pharmacology in Drug Development, 10(9), 1075-1088. https://doi.org/10.1002/cpdd.941

LinkOut - more resources